Actively Recruiting
Visual Function Abnormalities in Strabismus and Amblyopia and Response to Therapy
Led by The Cleveland Clinic · Updated on 2026-03-04
150
Participants Needed
1
Research Sites
368 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Amblyopia and strabismus are characterized by a reduction in visual acuity, contrast sensitivity, grating acuity, vernier acuity, reading difficulties and binocular visual function deficits. Treated patients have residual visual function deficits. The purpose of the current study is to quantify various visual functions in amblyopic and strabismic participants at baseline, during and at the completion of treatment.
CONDITIONS
Official Title
Visual Function Abnormalities in Strabismus and Amblyopia and Response to Therapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- History of amblyopia or presence of amblyogenic risk factors
You will not qualify if you...
- History of neurologic disorders
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Cleveland Clinic
Cleveland, Ohio, United States, 44195
Actively Recruiting
Research Team
K
Kimberly Baynes, MSN
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here